Novimmune's NI-0501 Granted Breakthrough Therapy Designation by US FDA for Treatment of Patients With Primary Hemophagocytic Lymphohistiocytosis (HLH)
March 16, 2016 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Mar 16, 2016) - Novimmune, a Swiss biotech company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...
Novimmune Completes CHF30 Million ($29.8 Million) Funding Round With Existing Shareholders
January 11, 2016 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Jan 11, 2016) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory and...
Change of Leadership at Novimmune S.A.
December 21, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Dec 21, 2015) - The Board of Directors at its meeting of December 16, 2015 appointed Ed Holdener as Chief Executive Officer of the Company, effective...
Novimmune Abstract Selected for the "Best of ASH" at the 2015 Annual Meeting of the American Society of Hematology (ASH)
December 15, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Dec 15, 2015) - Novimmune, a privately held, Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of...
Novimmune's Experimental Drug Selected for Oral Presentation at 2015 Annual Meeting of the American Society of Hematology (ASH)
December 01, 2015 09:00 ET
|
Novimmune
GENEVA, SWITZERLAND--(Marketwired - Dec 1, 2015) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory and...
Novimmune's New Rheumatoid Arthritis Drug Clears Regulatory Hurdles
November 02, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Nov 2, 2015) - Novimmune SA announced today that it received approvals from the U.S. Food and Drug Administration and the U.K. Medicines and Healthcare products...
Novimmune Announces Presentations at 2015 American College of Rheumatology (ACR) Annual Meeting
November 02, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Nov 2, 2015) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory...
Novimmune Sponsors Matthew and Andrew Akin Foundation '700 Miles to Hope' Bicycle Ride
September 14, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Sep 14, 2015) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory...
Novimmune and Baxalta ink international bispecific antibody collaboration
September 02, 2015 06:15 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Sep 2, 2015) - Novimmune SA announced today that it has signed an international research collaboration agreement with Baxalta Incorporated (Baxalta) to develop...